ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A | Science Translational Medicine

Skip to main content

ScienceMag.org

Read our COVID-19 research and news.

Article Information

vol. 7 no. 303 303ra137

DOI:

https://doi.org/10.1126/scitranslmed.aac4358

PubMed:

Published By:

American Association for the Advancement of Science

Print ISSN:

Online ISSN:

History:

Received for publication April 27, 2015
Accepted for publication July 28, 2015
.

Copyright & Usage:

Copyright © 2015, American Association for the Advancement of Science

Author Information

Sarah J. Hatsell¹,*,
Vincent Idone¹,*,
Dana M. Alessi Wolken¹,†,
Lily Huang¹,†,
Hyon J. Kim¹,†,
Lili Wang¹,
Xialing Wen¹,
Kalyan C. Nannuru¹,
Johanna Jimenez¹,
Liqin Xie¹,
Nanditha Das¹,
Genevieve Makhoul¹,
Rostislav Chernomorsky¹,
David D’Ambrosio¹,
Richard A. Corpina¹,
Christopher J. Schoenherr¹,
Kieran Feeley¹,‡,
Paul B. Yu²,
George D. Yancopoulos¹,
Andrew J. Murphy¹ and
Aris N. Economides¹,³,§

¹Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
²Brigham and Women’s Hospital, 20 Shattuck Street, Thorn Biosciences 1203, Boston, MA 02115, USA.
³Regeneron Genetics Center Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.

↵§Corresponding author. E-mail: aris{at}regeneron.com

↵* These authors contributed equally as first authors.
↵† These authors contributed equally as second authors.
↵‡ Present address: Ohio State University College of Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA.

Altmetric

Article usage

Article usage: August 2015 to May 2020

	Abstract	Full	Pdf
Aug 2015	1	0	0
Sep 2015	3221	773	1075
Oct 2015	335	126	148
Nov 2015	237	112	143
Dec 2015	205	63	96
Jan 2016	581	84	146
Feb 2016	617	106	119
Mar 2016	418	58	75
Apr 2016	379	79	117
May 2016	512	90	94
Jun 2016	362	57	78
Jul 2016	217	44	55
Aug 2016	292	42	95
Sep 2016	407	49	75
Oct 2016	378	71	78
Nov 2016	424	73	87
Dec 2016	283	45	67
Jan 2017	281	48	48
Feb 2017	275	55	63
Mar 2017	335	61	85
Apr 2017	320	57	72
May 2017	222	41	64
Jun 2017	206	74	84
Jul 2017	238	54	84
Aug 2017	222	30	63
Sep 2017	226	36	49
Oct 2017	302	46	56
Nov 2017	314	55	40
Dec 2017	190	49	21
Jan 2018	183	30	27
Feb 2018	212	35	28
Mar 2018	320	55	41
Apr 2018	263	42	35
May 2018	261	36	32
Jun 2018	199	23	30
Jul 2018	187	18	42
Aug 2018	79	44	43
Sep 2018	119	39	38
Oct 2018	140	39	36
Nov 2018	140	36	29
Dec 2018	137	25	23
Jan 2019	128	29	28
Feb 2019	151	29	29
Mar 2019	163	28	33
Apr 2019	176	47	27
May 2019	147	26	22
Jun 2019	84	19	23
Jul 2019	102	30	23
Aug 2019	82	26	12
Sep 2019	88	28	21
Oct 2019	103	36	20
Nov 2019	133	19	14
Dec 2019	120	20	18
Jan 2020	120	47	27
Feb 2020	93	43	36
Mar 2020	86	32	25
Apr 2020	118	27	29
May 2020	107	14	17

Science Translational Medicine: 7 (303)

Science Translational Medicine

Vol 7, Issue 303
02 September 2015

Table of Contents

Article Tools

Email

Thank you for your interest in spreading the word about Science Translational Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email

Your Name

Send To
Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A

Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

Your Personal Message

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Powerpoint
Print
Alerts

Please log in to add an alert for this article.

Log In with your AAAS ID

Sign In to Email Alerts with your Email Address
Email
Citation tools
ACVR1^R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A

By Sarah J. Hatsell, Vincent Idone, Dana M. Alessi Wolken, Lily Huang, Hyon J. Kim, Lili Wang, Xialing Wen, Kalyan C. Nannuru, Johanna Jimenez, Liqin Xie, Nanditha Das, Genevieve Makhoul, Rostislav Chernomorsky, David D’Ambrosio, Richard A. Corpina, Christopher J. Schoenherr, Kieran Feeley, Paul B. Yu, George D. Yancopoulos, Andrew J. Murphy, Aris N. Economides

Science Translational Medicine02 Sep 2015 : 303ra137

In patients with fibrodysplasia ossificans progressiva, the disease-causing mutation changes the ligand response profile of the ACVR1 receptor so that it is activated by the normally antagonistic ligand activin A.

Supplementary Materials

Citation Manager Formats

BibTeX

Bookends

EasyBib

EndNote (tagged)

EndNote 8 (xml)

Medlars

Mendeley

Papers

RefWorks Tagged

Ref Manager

RIS

Zotero
Share
ACVR1^R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A

By Sarah J. Hatsell, Vincent Idone, Dana M. Alessi Wolken, Lily Huang, Hyon J. Kim, Lili Wang, Xialing Wen, Kalyan C. Nannuru, Johanna Jimenez, Liqin Xie, Nanditha Das, Genevieve Makhoul, Rostislav Chernomorsky, David D’Ambrosio, Richard A. Corpina, Christopher J. Schoenherr, Kieran Feeley, Paul B. Yu, George D. Yancopoulos, Andrew J. Murphy, Aris N. Economides

Science Translational Medicine02 Sep 2015 : 303ra137

In patients with fibrodysplasia ossificans progressiva, the disease-causing mutation changes the ligand response profile of the ACVR1 receptor so that it is activated by the normally antagonistic ligand activin A.

Supplementary Materials
Share This Article:

My saved folders

Save to my folders

Log In with your AAAS ID

Stay Connected to Science Translational Medicine

Citing Articles in: